114 lines
No EOL
22 KiB
XML
114 lines
No EOL
22 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
|
|
|
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
|
<!-- AppResources meta begin -->
|
|
<meta name="paf-app-resources" content="" />
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- AppResources meta end -->
|
|
|
|
<!-- TemplateResources meta begin -->
|
|
<meta name="paf_template" content="" />
|
|
|
|
<!-- TemplateResources meta end -->
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548826" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548826/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
|
<!-- Logger end -->
|
|
|
|
<title>Fenugreek - LiverTox - NCBI Bookshelf</title>
|
|
|
|
<!-- AppResources external_resources begin -->
|
|
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
|
|
|
<!-- AppResources external_resources end -->
|
|
|
|
<!-- Page meta begin -->
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Fenugreek" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2018/01/29" /><meta name="citation_pmid" content="31644133" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548826/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Fenugreek" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2018/01/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548826/" /><meta name="description" content="Fenugreek is an herb prepared from the dried seeds of Trigonella foenum-graecum which is used for its antioxidant and glucose- and cholesterol-lowering effects in the treatment of fever, vomiting, poor appetite, diabetes and hypercholesterolemia. Fenugreek has not been implicated in causing liver injury." /><meta name="og:title" content="Fenugreek" /><meta name="og:type" content="book" /><meta name="og:description" content="Fenugreek is an herb prepared from the dried seeds of Trigonella foenum-graecum which is used for its antioxidant and glucose- and cholesterol-lowering effects in the treatment of fever, vomiting, poor appetite, diabetes and hypercholesterolemia. Fenugreek has not been implicated in causing liver injury." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548826/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Fenugreek/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548826/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
|
|
|
<!-- Page meta end -->
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8EC5757D7D169100000000006F0056.m_5" />
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
|
<body class="book-part">
|
|
<div class="grid no_max_width">
|
|
<div class="col twelve_col nomargin shadow">
|
|
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
|
<div class="sysmessages">
|
|
<noscript>
|
|
<p class="nojs">
|
|
<strong>Warning:</strong>
|
|
The NCBI web site requires JavaScript to function.
|
|
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
|
</p>
|
|
</noscript>
|
|
</div>
|
|
<!--/.sysmessage-->
|
|
<div class="wrap">
|
|
<div class="page">
|
|
<div class="top">
|
|
|
|
<div class="header">
|
|
|
|
|
|
</div>
|
|
|
|
|
|
|
|
<!--<component id="Page" label="headcontent"/>-->
|
|
|
|
</div>
|
|
<div class="content">
|
|
<!-- site messages -->
|
|
<div class="container content">
|
|
<div class="document">
|
|
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div></div></div>
|
|
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548826_"><span class="title" itemprop="name">Fenugreek</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 29, 2018</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Fenugreek.OVERVIEW"><h2 id="_Fenugreek_OVERVIEW_">OVERVIEW</h2><div id="Fenugreek.Introduction"><h3>Introduction</h3><p>Fenugreek is an herb prepared from the dried seeds of Trigonella foenum-graecum which is used for its antioxidant and glucose- and cholesterol-lowering effects in the treatment of fever, vomiting, poor appetite, diabetes and hypercholesterolemia. Fenugreek has not been implicated in causing liver injury.</p></div><div id="Fenugreek.Background"><h3>Background</h3><p>Fenugreek is an herb extract prepared from the dried seeds of Trigonella foenum-graecum (sicklefruit fenugreek), a plant belonging to the pea family (Fabaceae). It is native to India and northern Africa and is one of the oldest medicinal plants is continuous use. In Chinese medicine, fenugreek seeds were used as a tonic; in Indian medicine, as a stimulant to lactation; and, in many folk medicines as an aid to digestion and treatment of baldness. Investigation of its activity in animal models suggested that fenugreek extracts have antioxidant, antihyperlipidemic and hypoglycemic activities. Constituents of fenugreek extracts include dietary fibers, mucilages, steroid saponins, flavonoids, trigonelline, and volatile oils. The lipid- and glucose-lowering effects of fenugreek have been attributed to saponins. The benefits of fenugreek therapy in hypercholesterolemia and diabetes in humans have not been proven in rigorously designed prospective clinical trials. Nevertheless, fenugreek is widely used, often in combination with conventional therapies. The usual doses used to aid in the management of diabetes and hypercholesterolemia are variable, ranging from 2 to 100 grams daily taken in 2 or 3 divided doses either as capsules or as powder to prepare teas. Fenugreek preparations contain high levels of fiber, which may represent 50% of its constituents. Fenugreek is also used topically and in foods as a flavoring agent. Side effects of oral fenugreek are minor and include gastrointestinal upset, nausea, diarrhea, bloating, flatulence, and allergic reactions with facial edema, wheezing, dizziness and shock.</p></div><div id="Fenugreek.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Despite being widely used, fenugreek has not been implicated in cases of clinically apparent liver injury and, in prospective studies, has had no effect on serum enzyme levels. In vitro studies have demonstrated hepatoprotective activity of fenugreek extracts in several animal models. Because of the high fiber content, estrogenic and coumadin-like effects of fenugreek, it has a potential to cause herb-drug interactions particularly if taken in high doses with antiplatelet drugs and warfarin.</p><p>Likelihood score: E (unlikely cause of clinically apparent liver injury).</p><p>Other Names: Alholva, Bird’s Foot, Bockshornklee, Fenogreco, Greek Clover, Greek Hay, Hu Lu Ba, Methi, Trigonella, Woo Lu Bar.</p><p>Drug Class: <a href="/books/n/livertox/HerbalDietarySuppl/">Herbal and Dietary Supplements</a></p></div></div><div id="Fenugreek.PRODUCT_INFORMATION"><h2 id="_Fenugreek_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Fenugreek.BPI" class="box"><p>
|
|
<b>REPRESENTATIVE TRADE NAMES</b>
|
|
</p><p>Fenugreek – Generic</p><p>
|
|
<b>DRUG CLASS</b>
|
|
</p><p>Herbal and Dietary Supplements</p><p>SUMMARY INFORMATION</p><p>
|
|
<a href="https://nccih.nih.gov/health/fenugreek" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Fact Sheet at National Center for Complementary and Integrative Health, NIH</a>
|
|
</p></div></div><div id="Fenugreek.CHEMICAL_FORMULA_AND_STRUCTURE"><h2 id="_Fenugreek_CHEMICAL_FORMULA_AND_STRUCTURE_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Fenugreek.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548826/table/Fenugreek.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Fenugreek.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Fenugreek.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Fenugreek.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Fenugreek.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Fenugreek.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Fenugreek.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Fenugreek</td><td headers="hd_h_Fenugreek.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0977155295</td><td headers="hd_h_Fenugreek.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Herbal mixture</td><td headers="hd_h_Fenugreek.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Not Applicable</td></tr></tbody></table></div></div></div><div id="Fenugreek.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Fenugreek_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 29 January 2018</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Fenugreek.R1">Zimmerman HJ. Unconventional drugs. Miscellaneous drugs and diagnostic chemicals. In, Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott,1999: pp. 731-4.<div><i>(Expert review of hepatotoxicity published in 1999; fenugreek is not discussed).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R2">Seeff L, Stickel F, Navarro VJ. Hepatotoxicity of herbals and dietary supplements. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 631-58. <em>(Review of hepatotoxicity of herbal and dietary supplements [HDS]</em><div><i>; fenugreek is not discussed).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R3">Fenugreek. In, PDR for Herbal Medicines. 4th ed. Montvale, New Jersey: Thomson Healthcare Inc. 2007: pp. 319-20.<div><i>(Compilation of short monographs on herbal medications and dietary supplements).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R4">Sushma N, Devasena T. Aqueous extract of Trigonella foenum graecum(fenugreek) prevents cypermethrin-induced hepatotoxicity and nephrotoxicity. Hum Exp Toxicol 2010; 29: 311-9. [<a href="https://pubmed.ncbi.nlm.nih.gov/20147568" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20147568</span></a>]<div><i>(Fenugreek decreased the hepatic and renal toxicity of the pesticide cypermethrin in rats).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R5">Thirunavukkarasu V, Anuradha CV, Viswanathan P. Protective effect of fenugreek (Trigonella foenum graecum) seeds in experimental ethanol toxicity. Phytother Res 2003; 17: 737-43. [<a href="https://pubmed.ncbi.nlm.nih.gov/12916070" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12916070</span></a>]<div><i>(Fenugreek extracts decreased enzyme elevations and markers of lipid peroxidation in a rat model of alcohol hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R6">Ulbricht C, Basch E, Burke D, Cheung L, Ernst E, Giese N, Foppa I, et al. Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration. J Herb Pharmacother 2007; 7: 143-77. [<a href="https://pubmed.ncbi.nlm.nih.gov/18928139" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18928139</span></a>]<div><i>(Extensive review of laboratory and clinical data of medicinal effects of fenugreek; “Literature review reveals no reports of clinically significant harmful adverse effects,” no mention of effect on ALT levels or hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R7">Thompson Coon JS, Ernst E. Herbs for serum cholesterol reduction: a systematic view. J Fam Pract 2003; 52: 468-78. [<a href="https://pubmed.ncbi.nlm.nih.gov/12791229" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12791229</span></a>]<div><i>(Systematic review of literature found 5 randomized controlled trials of fenugreek in lowering serum cholesterol; cholesterol levels lowered by 15-33%; side effects were mild and largely gastrointestinal).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R8">Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. Therapeutic applications of fenugreek. Altern Med Rev 2003; 8: 20-7. [<a href="https://pubmed.ncbi.nlm.nih.gov/12611558" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12611558</span></a>]<div><i>(Review of the safety and efficacy of fenugreek, most studies showing some effect in lowering blood glucose in open labeled studies but without adequate controls; no reports of clinically significant adverse effects). </i></div></div></li><li><div class="bk_ref" id="Fenugreek.R9">Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des 2010;16: 2935-47. [<a href="https://pubmed.ncbi.nlm.nih.gov/20858178" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20858178</span></a>]<div><i> (Review of the safety and efficacy of herbal medications used to treat hyperlipidemia including fenugeek, mentions that it has not been associated with significant adverse events).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R10">Nathan J, Panjwani S, Mohan V, Joshi V, Thakurdesai PA. Efficacy and safety of standardized extract of Trigonella foenum-graecum L seeds as an adjuvant to L-Dopa in the management of patients with Parkinson's disease. Phytother Res 2014; 28: 172-8. [<a href="https://pubmed.ncbi.nlm.nih.gov/23512705" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23512705</span></a>]<div><i>(Controlled trial of fenugeek vs placebo in 50 patients with Parkinson disease found no change in serum ALT or AST levels during 6 months of therapy).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R11">Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014; 60: 1399-408. [<a href="/pmc/articles/PMC4293199/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4293199</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25043597" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25043597</span></a>]<div><i>(Among 839 cases of liver injury from drugs collected in the US between 2004 and 2013, 130 were due to various HDS products, none of which were attributed to fenugreek).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R12">Verma N, Usman K, Patel N, Jain A, Dhakre S, Swaroop A, Bagchi M, et al. A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes. Food Nutr Res 2016; 60: 32382. [<a href="/pmc/articles/PMC5061863/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5061863</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27733237" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27733237</span></a>]<div><i>(Among 150 patients with type 2 diabetes treated with fenugreek seed extract or placebo for 90 days, fasting blood glucose levels fell by 30% vs 17% in controls, but HgbA1c and serum aminotransferase levels were unchanged in both groups).</i></div></div></li><li><div class="bk_ref" id="Fenugreek.R13">Steels E, Steele ML, Harold M, Coulson S. Efficacy of a proprietary Trigonella foenum-graecum L. de-husked seed extract in reducing menopausal symptoms in otherwise healthy women: a double-blind, randomized, placebo-controlled study. Phytother Res 2017; 31: 1316-22. [<a href="https://pubmed.ncbi.nlm.nih.gov/28707431" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28707431</span></a>]<div><i>(Among 115 healthy, adult women with menopausal symptoms who were treated with a fenugreek seed extract or placebo for 12 weeks, several symptoms improved while "liver function tests remained within normal reference range").</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
|
|
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548826</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31644133" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">31644133</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/FentanylAndAnalogues/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/livertox/Fesoterodine/" title="Next page in this title">Next ></a></div></div></div></div>
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
<div class="bottom">
|
|
|
|
<div id="NCBIFooter_dynamic">
|
|
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
|
<component id="Breadcrumbs" label="helpdesk"/>-->
|
|
|
|
</div>
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
</div>
|
|
</div>
|
|
<!--/.page-->
|
|
</div>
|
|
<!--/.wrap-->
|
|
</div><!-- /.twelve_col -->
|
|
</div>
|
|
<!-- /.grid -->
|
|
|
|
<span class="PAFAppResources"></span>
|
|
|
|
<!-- BESelector tab -->
|
|
|
|
|
|
|
|
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK548826&ncbi_domain=livertox&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK548826/?report=printable&ncbi_app=bookshelf" /></noscript>
|
|
|
|
|
|
<!-- usually for JS scripts at page bottom -->
|
|
<!--<component id="PageFixtures" label="styles"></component>-->
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
|
</html> |